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Abstract
We identified MISC-1 (Mitochondrial Solute Carrier) as the C. elegans orthologue of mammalian OGC (2-oxoglutarate carrier).
OGC was originally identified for its ability to transfer a-ketoglutarate across the inner mitochondrial membrane. However,
we found that MISC-1 and OGC are not solely involved in metabolic control. Our data show that these orthologous proteins
participate in phylogenetically conserved cellular processes, like control of mitochondrial morphology and induction of
apoptosis. We show that MISC-1/OGC is required for proper mitochondrial fusion and fission events in both C. elegans and
human cells. Transmission electron microscopy reveals that loss of MISC-1 results in a decreased number of mitochondrial
cristae, which have a blebbed appearance. Furthermore, our pull-down experiments show that MISC-1 and OGC interact
with the anti-apoptotic proteins CED-9 and Bcl-xL, respectively, and with the pro-apoptotic protein ANT. Knock-down of
misc-1 in C. elegans and OGC in mouse cells induces apoptosis through the caspase cascade. Genetic analysis suggests that
MISC-1 controls apoptosis through the physiological pathway mediated by the LIN-35/Rb-like protein. We provide genetic
and molecular evidence that absence of MISC-1 increases insulin secretion and enhances germline stem cell proliferation in
C. elegans. Our study suggests that the mitochondrial metabolic protein MISC-1/OGC integrates metabolic, apoptotic and
insulin secretion functions. We propose a novel mechanism by which mitochondria integrate metabolic and cell survival
signals. Our data suggest that MISC-1/OGC functions by sensing the metabolic status of mitochondria and directly activate
the apoptotic program when required. Our results suggest that controlling MISC-1/OGC function allows regulation of
mitochondrial morphology and cell survival decisions by the metabolic needs of the cell.
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Introduction
Mitochondria are the sites of enzymatic reactions fundamental
for life, producing ,95% of cellular ATP in eukaryotic cells.
Mitochondria also play a dominant role in the control of apoptosis
(reviewed in [1]). Several mitochondrial proteins are required for
the intrinsic pathway of apoptosis. The succession of events from
mitochondrial fragmentation to cell death has been well
characterized and shown to be highly conserved from C. elegans
to mammals [2,3].
Mitochondria undergo constant rounds of fusion and fission to
form or break their tubular structure within the cell. In addition to
mitochondrial fragmentation during apoptosis [4], extensive
mitochondrial remodelling happens in response to metabolic
changes (reviewed in [5]). The exact mechanisms that control the
interdependence of metabolic rate and mitochondrial structure are
currently unknown. We investigated the possibility that mitochon-
drial metabolic proteins interact directly with members of the
apoptotic machinery to control mitochondrial morphology and
cell survival decisions. We focused on the mitochondrial 2-
oxoglutarate carrier (OGC) to test our hypotheses.
The nuclear gene OGC encodes a monomeric carrier protein
that resides in the inner mitochondrial membrane and is
responsible for the electroneutral transport of a-ketoglutarate
[6,7]. This gene has been studied mostly for its effects on cellular
metabolism. However, it has recently been shown that mammalian
OGC imports about 40% of mitochondrial glutathione (GSH), a
potent anti-oxidant peptide involved in oxidative stress response in
mammals and C. elegans. Also, its over-expression in NRK-52E
cells prevents chemically induced apoptosis [8–10]. These findings
suggest that OGC might be involved in stress response as well as
control of mitochondrial metabolism. In this report, we charac-
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(Mitochondrial Solute Carrier), and find a novel role for MISC-1/
OGC in apoptosis.
C. elegans has been used extensively to dissect the apoptotic
pathway at the genetic level. Programmed cell death in C. elegans
follows a linear genetic pathway involving ced-9/Bcl-2-like [11],
ced-4/Apaf1 [12,13] and ced-3/Caspase-9 [14]. Under non-
apoptogenic conditions, CED-9 binds to CED-4 at the outer
mitochondrial membrane to maintain it in its quiescent state [15].
Upon apoptotic stimuli, the BH3-only Bcl-2-family protein EGL-1
binds to CED-9 [16], which liberates CED-4 [17]. The now active
CED-4 interacts with and activates the effector caspase CED-3 in
the cytoplasm, thereby initiating a cascade of caspase activations
that causes the hallmark phenotypes of apoptosis.
Mitochondria-induced apoptosis can result from the opening of
channels called Mitochondrial Permeability Transition Pores
(MPTPs), which are located at the junctions of inner and outer
mitochondrial membranes. MPTP contributes to Mitochondrial
Outer Membrane Permeabilization (MOMP) during apoptosis
and allows exit of cytochrome c [18,19] and other mitochondrial
pro-apoptotic factors to the cytoplasm. MPTPs are multi-protein
complexes, composed of the Voltage-Dependent Anion Channel
(VDAC), the Adenine Nucleotide Translocase (ANT) and
Cyclophilin D (Cyp-D; [20–22]). Multiple regulators have been
identified, including the anti-apoptotic Bcl-2-family proteins Bcl-2
and Bcl-xL [23,18]. The identity of all MPTP components and
regulators is not yet known. ANT is an established component of
the MPTP in both mammals [24] and C. elegans [25]. We tested the
possible interaction of OGC and MISC-1 with components of the
MPTP.
Here we show that OGC and its C. elegans orthologue MISC-1
maintain the balance of fusion and fission events in human cells
and in C. elegans. Genetically, the absence of MISC-1/OGC results
in increased apoptosis rates through the physiological pathway.
Furthermore, we provide genetic and molecular evidence of the
involvement of MISC-1/OGC in control of insulin secretion and
germline stem cell proliferation. Our work points to a novel,
conserved and direct interaction between mitochondrial metabolic
carriers and the apoptotic machinery to determine cell survival
outcomes.
Results
misc-1 expression
We investigated the expression profile of the 2-oxoglutarate
carrier in C. elegans. Based on sequence similarity between MISC-1
and human OGC (72% amino acid identity; Supplementary
Figure S1), their localization to mitochondria, and the shared roles
of the two proteins (see below), we conclude that MISC-1 is the C.
elegans orthologue of OGC.
We generated an extrachromosomal transgenic line carrying
the full-length misc-1 gene fused to gfp and under control of
,1100 bp of the region 59 of the ATG codon. Although low
levels of reporter expression were observed ubiquitously (as
expected), a subset of organs showed higher expression of MISC-
1::GFP. GFP expression began early in embryogenesis in the
intestinal precursor cells (Fig. 1A–B). The protein exhibited
intestinal and neuronal localization in newly hatched L1s
(Fig. 1C–D), while it was mainly present in the anterior pharynx
in adults (Fig. 1E–F). A similar expression pattern was observed
in a separate extrachromosomal transgenic line carrying a misc-1
promoter GFP fusion construct (data not shown). Overall, this
expression pattern suggests that MISC-1 is required in tissues
with high energy demands, i.e. the intestine in developing
animals and the pharynx in adults. This is consistent with the
increased expression of our MISC-1::GFP reporter in calorie-
restricted animals (Figure S2). It is interesting to note that in
humans, OGC is most highly expressed in the heart (UCSC
Genome Browser, [26]), another organ with high energy
demands.
Although MISC-1/OGC is expected to be a mitochondrial
carrier, we could find no published in vivo localization data for any
organism. C. elegans embryonic and larval cells exhibited a typical
mitochondrial pattern [27] for the localization of MISC-1::GFP
(Fig. 1A–D). Co-localization of MISC-1::GFP and the mitochon-
dria-specific marker MitoTracker Red CMXRos in muscle and
seam cells indicates that MISC-1 is a mitochondrial protein
(Fig. 1G–H).
MISC-1 and OGC regulate mitochondrial morphology
Under normal cellular conditions, mitochondria are mostly
found fused in branched structures. To assess the effects of misc-1
knock-down on mitochondrial morphology, we used a transgenic
line with GFP targeted to mitochondria and under control of the
muscle-specific myo-3 promoter (myo-3p::mito::gfp; [28]). misc-1
RNAi resulted in robust (84%) down-regulation of MISC-1
protein levels (Figure S3) and was therefore deemed an
appropriate system for the study of misc-1 function. misc-1 RNAi
treatment resulted in mitochondrial fragmentation in the mito::gfp
strain (Fig. 2A,B). In order to understand if this phenotype was
specific to the mitochondria and not the result of misc-1-mediated
defects in muscle fibres, we also tested the effect of misc-1 RNAi on
a strain carrying myo-3p::myo-3::gfp [29], a marker for the structure
and organization of body wall muscle. Our results indicate that
misc-1 RNAi does not affect muscle structure (Figure S4; see also
Fig. 3C–D). MISC-1 seems therefore to specifically control
mitochondrial morphology.
To determine whether the effect of the 2-oxoglutarate carrier on
mitochondrial morphology is conserved in mammals, we knocked
down the misc-1 human orthologue, OGC, in Human Embryonic
Kidney 293 (HEK293) cells (Fig. S3). Staining with MitoTracker
showed that siRNA against OGC resulted in a mitochondrial
fragmentation phenotype reminiscent of misc-1 knock-down worms
(Fig. 2C,D). MISC-1 and OGC have the same effect on
mitochondrial morphology in C. elegans and human cells,
respectively.
Animals homozygous for the misc-1(tm2793) knock-out allele
are morphologically normal, have the same developmental time
as wild type (measured as time from egg laying to day one of
adulthood), and have normal fat staining and lifespan (data not
shown). However, when analyzed by transmission electron
microscopy, we observed morphological defects in the mitochon-
dria of misc-1 animals. On average, the mitochondria of knock-
out animals were reduced in size and more spherical in shape
compared to N2 controls (Fig. 3A,B). Moreover, they displayed a
reduced number of disorganized and abnormal mitochondrial
cristae (Fig. 3C,D). These features suggest that absence of MISC-
1 shifts the equilibrium of mitochondrial dynamics in the
direction of fission and are in agreement with the mitochondrial
fragmentation phenotype we observed with the mito::gfp strain.
Furthermore, the absence of a key mitochondrial inner
membrane protein disrupts normal formation or maintenance
of cristae.
Lack of MISC-1 results in increased germline apoptosis
Mitochondrial fragmentation is a hallmark of apoptosis in
mammals and in C. elegans [4]. We used SYTO12 to stain
apoptotic bodies in the adult germline in N2 and in the misc-1
OGC Links Metabolism and Apoptosis
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17827Figure 1. MISC-1::GFP reporter expression and its subcellular localization during C. elegans development. (A–B) GFP image and GFP/
DIC overlay of MISC-1::GFP expression in an early embryo. Expression is in intestinal precursor cells and has a typically mitochondrial sub-cellular
localization. (C–D) GFP image and GFP/DIC overlay of reporter expression in a newly hatched L1 animal. Expression can be observed in the intestine
(arrowhead points to one typical cell) and in four head neurons (arrows). As in (A,B), the GFP reporter also has a string-like appearance typical of
mitochondria. (E–F) GFP image and GFP/DIC overlay of reporter expression in an adult. Expression is strongest in the pharyngeal corpus. (G) Muscles
of a MISC-1::GFP adult. MISC-1::GFP co-localizes with muscle mitochondria stained with the dye Mitotracker CMXRos (MT), as seen in the overlay. (H)
Seam cell syncytium of a MISC-1::GFP adult. Mitochondria were stained with Mitotracker CMXRos and nuclei were counterstained with DAPI. The
overlay shows the alternating pattern of mitochondria and nuclei in the seam cell syncytium, and illustrates how MISC-1::GFP co-localizes with the
mitochondria.
doi:10.1371/journal.pone.0017827.g001
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apoptotic corpses per gonadal arm in misc-1 knock-outs
(Fig. 4A,B).
Since an increase in the number of apoptotic corpses could
be caused either by increased apoptosis or by a defect in
corpse removal, we used a transgenic line carrying a CED-
1::GFP reporter [30] to monitor corpse engulfment. CED-1 is a
receptor localized to the membrane of the sheath cells in the
somatic gonad and is responsible for the recognition of cell
corpses and the initiation of their engulfment and removal. We
observed a two-fold increase in the number of corpses engulfed
by CED-1::GFP(+) cells in animals treated with misc-1 RNAi,
compared to adults treated with control RNAi (Figure S5).
These results indicate that misc-1 RNAi does not impair the
mechanism of cell corpse removal. We conclude that absence or
decreased levels of MISC-1 increase the frequency of germline
apoptosis.
In order to assess if reduced levels of OGC cause apoptosis in
mammalian cells, we knocked-down mouse OGC in the MIN6
mouse insulinoma cell line [31] with an shRNA strategy. OGC
knock-down caused robust cleavage and activation of Caspase-3,
an established marker of activation of apoptosis (Fig. 4C). We
conclude that lower levels of the 2-oxoglutarate carrier induce a
phylogenetically conserved apoptosis program that is conserved
from nematodes to mammals.
misc-1 acts through the physiological pathway of
apoptosis
The increased levels of apoptosis observed upon knocking down
misc-1 were controlled at the genetic level, since a ced-3(lf)/Caspase-
9 genetic background obliterated apoptosis caused by misc-1 RNAi
(Fig. 4D). In C. elegans, apoptosis can be triggered by three main
pathways: (a) the DNA damage pathway, the main mediator being
the C. elegans p53 orthologue CEP-1 [32]; (b) the cytoplasmic stress
pathway, mediated by LET-60/K-Ras [33], and (c) the physiolog-
ical pathway, mediated by the Retinoblastoma (Rb)-like protein
LIN-35 [34]. All three pathways ultimately converge on the CED-
9/CED-4/CED-3 core apoptotic machinery.
misc-1 RNAi administered to wild-type N2 (Fig. 4D) recapitulated
t h eg e r m l i n ea p o p t o s i sp h e n o t y p eo b s e r v e di nmisc-1 knock-out worms
(see Fig. 4B). This result, and the assessed efficiency of misc-1 RNAi in
down-regulating MISC-1 protein levels (Fig. S3), further confirms that
RNAi is an appropriate tool to study misc-1 function. We treated
mutants in each of the three major apoptosis pathways with misc-1
RNAi and assessed apoptosis levels by SYTO12 staining (Fig. 4D).
The cep-1(lf)/p53 background did not affect the ability of misc-1 RNAi
to increase the number of apoptotic corpses. Using the let-60(n1046)/
K-Ras gain of function allele, which increases the basal rate of
apoptosis through the cytoplasmic stress pathway, misc-1 RNAi
increased the apoptotic rate in an additive fashion (not synergistic),
indicating that misc-1 does not function through this pathway. By
contrast, a lin-35(lf) mutant abrogated the apoptosis phenotype
induced by misc-1 RNAi. These results suggest that misc-1 acts through
the LIN-35/Rb-mediated physiological pathway of apoptosis.
MISC-1 and OGC interact with proteins involved in the
activation of apoptosis
Since we found that misc-1 modulates mitochondrial fragmen-
tation, cristae morphology and apoptosis, which are features also
Figure 2. MISC-1/OGC is required for normal mitochondrial
morphology in C. elegans and human cells. (A) Control RNAi and
(B) misc-1 RNAi on a transgenic strain carrying a muscle-specific,
mitochondrially tagged form of GFP (mitoGFP). These confocal images
show that misc-1 knock-down causes mitochondrial fragmentation: the
mitochondrial network breaks down because fission is more prevalent
than fusion and total mitochondrial length is shorter than wild type. (C)
Mitotracker staining and DAPI counterstaining of HEK293 cells
transfected with the mammalian scrambled siRNA control vector.
Mitochondria of transfected cells form organized networks, as expected.
(D) Mitotracker staining and DAPI counterstaining of cells transfected
with the OGC siRNA vector. These images show that downregulation of
OGC in HEK293 cells results in mitochondrial fragmentation. *Trans-
fected cells, as assessed by GFP fluorescence conferred by the
transfected siRNA vector. MT: staining with MitoTracker CMXRos.
doi:10.1371/journal.pone.0017827.g002
Figure 3. Mitochondrial ultrastructure is abnormal when MISC-
1 is absent. Shown are low (A–B) and high (C–D) magnification
images of TEM cross sections taken from the head region of N2 (A,C)
and misc-1 mutant (B,D) day 1 adults. Low magnification images show
that compared with N2, the mitochondria of misc-1 worms are smaller
and more spherical. High magnification images indicate that compared
to N2 controls, the mitochondrial cristae of the misc-1 mutant are more
disorganized, possess increased blebbing characteristics and adopt
more irregular orientations. Furthermore, the cristae of misc-1 animals
are fewer in number. These images point to a function of MISC-1 in the
stabilization of the inner mitochondrial membrane. The lower number
of cristae in the absence of MISC-1 suggests that mutants have lower
mitochondrial metabolic rates. Bars correspond to 500 nm in A, C and
D, 1 mmi nB .
doi:10.1371/journal.pone.0017827.g003
OGC Links Metabolism and Apoptosis
PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17827Figure 4. Absence of MISC-1 increases apoptosis in the C. elegans germline. (A) SYTO12 staining of apoptotic cell corpses (arrowheads) in
the germline of N2 and misc-1 knock-out. misc-1 knock-out day 1 adults have an increased number of apoptotic events per gonadal arm. (B) Scoring
of SYTO12-positive apoptotic corpses in N2 and misc-1 knock-out. N2 had on average 3.2 apoptotic corpses per gonad arm, whereas misc-1 had 6.2
per gonad arm. Absence of MISC-1 therefore results in a two-fold increase in apoptotic events in the germline. *t-test P,0.0001. N=27 for N2 and
N=30 for misc-1. Error bars: 6SEM. (C) OGC knock-down induces apoptosis in MIN6 cells. MIN6 cells were either untransfected [(-) lane], transfected
with a scrambled control shRNA vector (Scr. lane) or with an shRNA vector targeting mouse OGC (OGC lane). Cell lysates from the three treatments
were used for a Western blot employing an antibody that recognizes both total Caspase-3 and cleaved Caspase-3. The latter is the active, pro-
apoptotic form of the caspase and is therefore a marker of apoptosis. The Western blot shows that knock-down of OGC results in Caspase-3 activation
and therefore apoptosis in MIN6 cells. Similar results were obtained with MIN6 cells at two different passages. (D) misc-1 mediates apoptosis through
the physiological pathway of apoptosis. Synchronized animals with different genetic backgrounds were fed either control or misc-1 RNAi from the L1
stage and were stained with SYTO12 on day 1 of adulthood. SYTO12-positive apoptotic bodies per gonad arm were scored. ced-3 mutants were used
as a control, since mutations in this gene encoding an effector caspase obliterates germline apoptosis. cep-1/p53 mutants suppress the DNA-damage
pathway of apoptosis. lin-35 mutants lack the physiological pathway of apoptosis. Worms carrying a let-60/K-Ras gain-of-function allele have
increased apoptotic rates through the cytoplasmic stress pathway. The data indicate that mutations in lin-35 suppress the apoptotic phenotype of
misc-1 RNAi, indicating that misc-1 controls apoptosis through the physiological pathway of apoptosis. *t-test P,0.001.
{t-test P,0.05.
doi:10.1371/journal.pone.0017827.g004
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components or regulators of the MPTP, specifically Bcl-xL and
ANT. We performed a co-immunoprecipitation experiment using
an antibody against ANT in HEK293 cells. ANT pulled down Bcl-
xL as expected, and it also precipitated OGC (Fig. 5). Likewise,
Bcl-xL co-precipitated ANT and OGC (data not shown). As a
control, we tested a subunit of complex IV of the electron
transport chain, which is also a mitochondrial inner membrane
protein. This protein was not detected in the co-immunoprecip-
itated fraction; it was only present in the input/supernatant.
We observed similar interactions for MISC-1 in C. elegans.W e
did pull-down experiments in wild type and in our MISC-1::GFP
over-expressing transgenic line with several combinations of
antibodies and were able to confirm the interaction of MISC-1,
CED-9/Bcl-2 and ANT (Figure S6). These pull-down experiments
indicate that MISC-1 and OGC interact with proteins involved in
the control of apoptosis.
misc-1 mutations suppress the dauer constitutive
phenotype of daf-2
MISC-1 is a metabolic protein, controls mitochondrial function
and interacts with CED-9, whose orthologue is Bcl-xL. Interest-
ingly, transgenic mice with strong over-expression of Bcl-xL in
their pancreatic beta-cells were previously shown to have altered
glucose-sensing at the mitochondria and impaired glucose-
stimulated insulin release [35]. This observation suggests the
possibility that Bcl-xL, like the related pro-apoptotic protein Bad
[36], may play a role in insulin release independent of its role in
apoptosis. We took advantage of the genetic tools afforded by C.
elegans to investigate a possible role for misc-1 in insulin signalling in
vivo. The Insulin/Insulin-like Signalling (IIS) pathway is well
conserved between C. elegans and mammals (reviewed in [37]). In
C. elegans, the Insulin-like Growth Factor 1 Receptor (IGF1R) is
encoded by daf-2 (DAuer Formation) [38–40]. Mutations in this
gene and reduced IIS result in dauer formation, which is a larval
diapause state [41–43].
To test the possibility that MISC-1 might play a role in insulin
secretion in C. elegans, we first tested a possible genetic interaction
between misc-1 and daf-2/IGF1R. We created a double mutant
carrying the hypomorphic allele daf-2(m41) and the knock-out
allele misc-1(tm2793) to ask whether misc-1 modified the daf-2
dauer-constitutive phenotype (Fig. 6A). m41 animals constitutively
enter the dauer diapause stage at non-permissive temperatures
(.22uC). All daf-2 animals entered the dauer stage at both 22.5uC
and 25uC, but no daf-2;misc-1 animals entered the dauer stage at
22.5uC and only 22% formed dauer larvae at 25uC. Therefore
misc-1 substantially suppresses the dauer phenotype of daf-2. The
suppressive effects of the mutation are stronger at lower
temperatures, probably because m41 is a temperature-sensitive
allele with a stronger phenotype at higher temperatures.
MISC-1 modulates DAF-28 secretion
The suppression of the daf-2 dauer-constitutive phenotype by
misc-1(tm2793) could be interpreted in at least two ways: (a) misc-
1 could be genetically downstream of daf-2 or part of a pathway
downstream of the insulin-like pathway; (b) mutations in misc-1
may positively affect insulin secretion, which in turn would
compensate for the partial loss of DAF-2 function due to the
hypomorphic mutation m41. To address this issue, we employed
a strain carrying a translational fusion of the C. elegans insulin
DAF-28 and GFP (DAF-28::GFP; [44]). We subjected the DAF-
28::GFP strain to misc-1 RNAi by feeding. DAF-28::GFP is
secreted by the head neurons and the posterior intestine into the
pseudo-coelomic fluid, where it is picked up by scavenging cells
called coelomocytes. Among a total of six coelomocytes, the
number containing DAF-28::GFP (GFP(+)) is proportional to the
amount of secreted insulin [44]. When we compared the
number of GFP(+) coelomocytes in worms treated with control
and misc-1 RNAi, we observed that knock-down of misc-1
induced an increase in GFP(+) coelomocytes (average of two
independent experiments; Fig. 6B). In control RNAi animals, we
observed no more than two GFP(+) coelomocytes, whereas we
observed three GFP(+) coelomocytes in 21% of misc-1 RNAi-
treated adults, four GFP(+) coelomocytes in 4.6% of the adultss
and five GFP(+) coelomocytes in 2.3% of the adults observed.
The results show a statistically significant increase in DAF-
28::GFP secretion in worms treated with misc-1 RNAi (P,0.05
by two-way ANOVA).
The DAF-28 protein acts as a DAF-2 receptor agonist, but the
C. elegans genome encodes over 40 insulin-like proteins, some being
agonists and some antagonists of DAF-2 [44–46]. To corroborate
the DAF-28::GFP reporter results as a general quantitative marker
of insulin secretion, we measured the amount of glucose in misc-1
and wild type N2 mixed-stage populations. We reasoned that if
indeed insulin secretion is increased in misc-1 mutants, then their
glucose utilization should increase and the total glucose level
should drop, compared to normal animals. In fact, we observed a
6% decrease (t-test P=0.0054) in glucose levels in the misc-1
mutant (Fig. 6C), a result consistent with an increase in insulin
secretion when MISC-1 levels are reduced. Organismal levels of
ATP are not affected by absence of MISC-1 (Fig. 6D), indicating
that ATP may not be responsible for the induction of insulin
secretion in the case of misc-1 insufficiency.
misc-1 activity negatively modulates germline
proliferation
The C. elegans germline is a syncytium of nuclei that mature as
they migrate from a distal to a proximal position and eventually
become oocytes. Notch signaling initiated from the Distal Tip Cell
(DTC) regulates the balance between proliferation (mitosis) and
differentiation (meiosis) of these germline nuclei. The DTC
produces the Notch ligand LAG-2 [47–49], which activates the
GLP-1/Notch receptor in nearby germ cells and maintains these
cells in the undifferentiated (mitotic) state [50,51]. A recent report
showed that increased insulin signalling can increase germ cell
Figure 5. OGC interacts with Bcl-xL and ANT. We performed a co-
immunoprecipitation experiment in HEK293 cells using an antibody
against ANT, which is an integral component of the MPTP. We were
able to detect Bcl-XL, OGC and ANT in the co-immuno precipitant. As a
control protein, we chose subunit 1 of complex IV of the electron
transport chain, which is also localized to the inner mitochondrial
membrane. This control protein did not co-immunoprecipitate with Bcl-
xL, OGC and ANT, but was present in the supernatant (input). We
obtained similar results by immunoprecipitation with an antibody
against Bcl-xL (data not shown). Co-IP: co-immunoprecipitation. WB:
western blot.
doi:10.1371/journal.pone.0017827.g005
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effect of insulin signalling on female reproduction was observed in
mouse [53].
We investigated the possibility that the increased insulin
secretion in misc-1 mutants could have an effect on germline
proliferation. Proliferative germ cells in late prophase and early
mitotic M-phase are positive for histone 3 (H3) phosphorylation
(pH3; [54,55]). We performed immunostaining of dissected
germlines from wild type and misc-1 knock-out mutants with a
pH3 antibody. The results show that absence of MISC-1 greatly
increases the number of pH3-positive, mitotic germline stem cells
(Fig. 7A,B) and causes an extended mitotic zone (data not shown).
pH3 immunostaining strongly suggests that absence of MISC-1
favours mitosis (self-renewal) over meiosis (differentiation) in
germline stem cells.
To assess the involvement of LAG-2, we employed a transgenic
line expressing a GFP reporter under the control of the lag-2
promoter (lag-2p::gfp; [56]). This reporter is expressed in the DTCs
and its processes, called cytonemes (Fig. 7C,D). We found that the
cytonemes of animals treated with misc-1 RNAi were longer than
the ones in control animals (Fig. 7C–E). Knock-down of misc-1
resulted in a two-fold increase in the length of the cytonemes
(mean 6 SEM: control RNAi=74.9610.80 mm, misc-1
RNAi=150.9629.14 mm; t-test P=0.0080). We assessed lag-
2p::gfp expression by microscopy in animals treated with control
or misc-1 RNAi, but were unable to detect statistically significant
differences between the two treatments (Fig. 7F). We concluded
that upregulation of lag-2 was not responsible for the extended
cytonemes and mitotic zones of misc-1 mutants. Although the
length of the cytonemes may be positively correlated with the
number of germline cells in a mitotic state, this is independent of
lag-2 expression. The germline stem cell proliferation phenotype
obtained by lack of MISC-1 is therefore consistent with an
increase in insulin signalling.
Figure 6. Absence of MISC-1 has positive effects on insulin secretion. (A) We assessed genetic interactions between misc-1 and the
hypomorphic allele daf-2(m41). Mutations in daf-2 result in constitutive dauer formation at 22.5uC and 25uC. However, the double mutant daf-2;misc-1
worms did not arrest at the dauer stage at 22.5uC, and only 22.5% of the double mutants formed dauer larvae at 25uC. These data show that absence
of misc-1 expression suppresses the dauer phenotype conferred by daf-2 mutations. T-test P=0.0021. (B) We tested the possibility that the daf-2
suppression by misc-1 was due to an increase in insulin secretion, which could over-ride the hypomorphic allele m41. We measured insulin secretion
by scoring GFP(+)( i.e. DAF-28::GFP-positive) coelomocytes in a transgenic strain upon misc-1 knock-down. misc-1 RNAi animals (N=44) had on
average more GFP(+) coelomocytes than control worms (N=33) (two-way ANOVA P=0.04). These data suggest that misc-1 knock-down increases
insulin secretion. (C) We quantified glucose concentration in N2 wild type or misc-1 knock-out animals, and observed a 6% reduction in glucose
concentration in misc-1 mutants, compared to control (t-test P=0.0054). The amount of glucose was normalized to protein content. (D)W e
quantified the amount of cellular ATP in N2 and misc-1 mutants, and observed no significant difference in the concentration of ATP between the two
strains (t-test P=0.09).
doi:10.1371/journal.pone.0017827.g006
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We identified misc-1, the C. elegans orthologue of human OGC.
By studying misc-1 in nematodes, we uncovered new functions for
this gene that are conserved in higher eukaryotes. We showed that
MISC-1/OGC is not merely involved in regulation of mitochon-
drial metabolism by participating in the malate-aspartate shunt.
The protein seems to participate in a higher order of metabolic
regulation by interacting with Bcl-2-family members and by
regulating insulin secretion. Specifically, our experiments in C.
elegans and mammalian cells show that MISC-1 and OGC regulate
mitochondrial fusion/fission, cell death and interact with regula-
tors of apoptosis.
First, we showed that reducing or eliminating expression of
MISC-1/OGC resulted in mitochondrial fragmentation in C.
elegans and in human cells. The mitochondrial fragmentation
phenotype and the concomitant reduction in cristae number in
misc-1 knock-out animals suggest a reduction in mitochondrial
metabolism (reviewed in [5]). Mitochondrial metabolism also
decreases and cristae condense in the absence of the fusion
machinery [57]. For instance, loss of function of Mitofusin-2
(Mfn2) – a key protein involved in mitochondrial fusion - in cell
Figure 7. Absence of MISC-1 positively affects germline proliferation. (A) Immunostaining with a-phospho-H3 (pH3, left panel) and DAPI
staining (right panel) of dissected germlines. Nuclei positive for phospho-H3 are actively undergoing mitosis. We observed an increase in mitotic cells
in the germline of misc-1 knock-out animals, compared to wild type (WT) control. (B) Quantification of phospho-H3-positive nuclei in dissected
germlines of wild type (WT) and misc-1 knock-out animals. While wild type had on average 2.63 pH3-positive nuclei, misc-1 worms had 10.2 pH3
positive cells per gonadal arm (t-test P,0.0001). (C–D) Transgenic animals expressing a lag-2p::gfp reporter were exposed to either control (empty)
RNAi vector (C) or misc-1 RNAi (D). misc-1 knock-down results in longer DTC cytonemes than control (arrows delineate the length of the cytonemes).
(E) Measurement of cytoneme length in control animals and animals exposed to misc-1 RNAi. The mean cytoneme length was 74.9 mm in control,
while it was 150.9 mmi nmisc-1 knock-down worms. Cytonemes in misc-1 knock-down worms were therefore twice as long as in control (unpaired t-
test P=0.0080). (F) Absence of MISC-1 does not affect lag-2 expression. We quantified reporter expression with ImageJ. We observed no difference in
GFP expression between control worms and misc-1 RNAi-treated worms (t-test P=0.3137). All error bars represent 6SEM.
doi:10.1371/journal.pone.0017827.g007
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reduces mitochondrial potential [58]. Mfn2 expression is down-
regulated in the Zucker rat model of obesity [57,58] and in human
subjects with obesity or diabetes [59]. Hence, mutations affecting
mitochondrial structure also affect metabolism. Here we provide
an example that the opposite is also true: a metabolic protein
affects mitochondrial structure.
The mitochondrial fragmentation conferred by misc-1 knock-out
or knock-down could be mediated by its physical interaction with
CED-9/Bcl-2, which is a component of the core apoptotic
machinery. The fact that knocking-down misc-1 in C. elegans and
OGC in human cells resulted in the same phenotype –
mitochondrial fragmentation – suggests that MISC-1/OGC might
be part of an ancient, phylogenetically conserved mechanism to
induce mitochondrial fragmentation. This hypothesis is strength-
ened by the observation that CED-9 physically interacts with
FZO-1/Mfn1,2 to promote mitochondrial fusion [60].
The interaction of MISC-1/OGC with CED-9/Bcl-2 may not
be unique, as other mitochondrial proteins localized to the inner
mitochondrial membrane might similarly interact with Bcl-2-
family members in order to regulate the mitochondrial fusion/
fission equilibrium according to metabolic needs. An example of
such a protein is ANT, the primary role of which is to mediate the
exchange of ADP and ATP across the inner mitochondrial
membrane. MISC-1/OGC and ANT are of similar size, share
protein domains (three solute carrier or SolCar domains), and are
both localized to the inner mitochondrial membrane [61].
Our data suggest that MISC-1 and OGC participate in an
evolutionarily conserved apoptosis program. Furthermore, we
showed that misc-1 modulates apoptosis through the physiological
(LIN-35/Rb) pathway. This pathway is not activated by stress, but
functions in the C. elegans germline during oocyte production
[33,34], similarly to apoptosis during oocyte production in
humans. It has been shown that the physiological pathway
activates the core apoptotic machinery through an unknown
mechanism, independent of the BH3-only protein EGL-1 [33].
We hypothesize that the physiological pathway of apoptosis is
triggered by the efflux of mitochondrial pro-apoptotic factors
controlled by the function of MISC-1/OGC and the MPTP.
It has been suggested that the MPTP might function as a low-
affinity Ca
2+ channel [62]. It is interesting to speculate that Ca
2+
may mediate the apoptosis and insulin secretion phenotypes
observed in the absence MISC-1/OGC, since we were unable to
detect an increase in ATP levels in whole-organism extracts from
misc-1 mutants that exhibited higher insulin secretion. It would be
interesting to measure ATP levels specifically in the C. elegans
insulin-secreting cells. However, because of the lack of techniques
to dissect single tissues in the adult, we measured total ATP levels,
thereby possibly diluting any effect misc-1 mutations might have on
ATP production in insulin-producing cells. Whether through
release of mitochondrial Ca
2+ or not, we offer genetic and
molecular evidence that absence of MISC-1 results in increased
insulin secretion in C. elegans.
Our experiments do not distinguish whether MISC-1 has effects
on secretion of only DAF-28 or if it is a more general modulator of
insulin secretion. Further studies should be undertaken to clarify
this issue. a-ketoglutarate, the main substrate of MISC-1/OGC, is
an insulin secretagogue (reviewed in [62]). Furthermore, over-
expression of Bcl-xL in mouse b-cells impairs glucose- and KCl-
stimulated insulin secretion and intracellular Ca
2+ levels [35]. Bcl-
2-proteins could modulate insulin secretion via release of
mitochondrial and ER Ca
2+ [63]. It is therefore possible that
MISC-1/OGC affects insulin secretion by modulating the
function of Bcl-2 proteins, probably through regulation of Ca
2+
release from mitochondrial stores. Interestingly, an expression
microarray study [64] showed that the gene encoding OGC is also
down-regulated in muscles of individuals affected by type 2
diabetes or with a family history of the disease, compared to
controls.
Absence of MISC-1 favours mitotic proliferation of germline
stem cells. This result seems to further corroborate the increase in
insulin secretion in misc-1 knock-down and knock-out animals. In
fact, increased insulin secretion and insulin signalling induces
germline proliferation in C. elegans, independently of the Notch
ligand LAG-2 [52]. Here we show that absence of MISC-1
induces germline stem cell proliferation independently of LAG-2.
We considered the possibility that increased germline stem cell
proliferation may represent a compensatory mechanism for the
increased apoptotic rate in the germline of misc-1 animals.
However, several reports suggest that germline stem cell
proliferation and apoptotic rates are not interdependent. For
example, absence of the germline RNA helicase CGH-1 results in
increased apoptosis and decreased germline proliferation [65],
whereas absence of the RNA binding protein GLD-1 results in
reduced apoptosis and increased germline proliferation [66]. We
speculate that increased insulin secretion stimulates the growth of
DTC cytonemes and that longer cytonemes are responsible for
maintaining the extended mitotic zone observed in misc-1
germlines. To the best of our knowledge, such an association
between cytoneme length and germline stem cell proliferation has
not been reported before.
In conclusion, we identified MISC-1/OGC as a novel regulator
of mitochondrial fusion/fission, apoptosis, insulin secretion and
germline proliferation. The functions of this protein seem to be
phylogenetically conserved from nematodes to mammals. Our
data suggest that MISC-1/OGC has a role in assessing the
metabolic status of a cell and subsequently in making cell survival
decisions. We find it intriguing that a primarily metabolic protein
like MISC-1/OGC plays roles in such a wide array of functions.
The study of other metabolic mitochondrial carriers in the context
of their wider cellular functions might elucidate the complex
mechanisms underlying the integration of cell survival signals with
cell metabolism.
Materials and Methods
Strains
The following strains were used: N2, daf-2(m41) (DR41), misc-
1(tm2793) (DR2520), daf-2(m41);misc-1(tm2793) (DR2540), daf-
28p::daf-28::gfp, ced-1::gfp (MD701), ced-3(n717), cep-1(gk139), lin-35
(n745), let-60(n1046), mgIs[rol-6(su1006);myo-3::mito::gfp] (DM8006),
myo-3p::myo-3::gfp (RW1596), qIs56[lag-2p::gfp; unc-119(+)].A l ls t r a i n s
were maintained on agar plates spread with E. coli OP50 using standard
techniques [67]. DR2520 was obtained by out-crossing the original
knock-out strain received from the Knock-out Consortium three times
with wild-type N2.
Cell culture
HEK293 and MIN6 cells were cultured in Dulbecco/Vogt
modified Eagle’s Minimal Essential Medium (DMEM) containing
25 mM glucose, 10% heat-inactivated Fetal Calf Serum (FCS) and
1% penicillin/streptomycin at 37uC and 5% CO2.
Transgenic lines
For the transgenic line carrying the MISC-1::GFP reporter, we
amplified 1165 bp upstream of the misc-1 ATG codon and the full
misc-1 gene from N2 genomic DNA. We then fused misc-1 to gfp
using the stitching PCR method [68]. The transgenes were
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N2 hermaphrodites according to established protocols [69].
Although the transgene was not integrated in the genome,
,90% of animals in each generation carried the transgene.
RNAi, siRNA and shRNA
RNAi by feeding was performed as previously described
[70,71]. The clone used for misc-1 RNAi was B0432.4. misc-1
RNAi and the empty RNAi vector (L4440; [70]) were propagated
in Escherichia coli HT115 and administered to worms according to
established feeding RNAi protocols [72]. For siRNA in HEK293
cells, we designed oligos targeting OGC with the software
OligoEngine Workstation. The oligos were annealed in the siRNA
vector pSuper.gfp/neo (OligoEngine) to make pSuperOGC. 1 mg
of pSuperOGC or a control vector containing a scrambled
mammalian sequence (X-Scramble) were transfected in HEK293
cells using Lipofectamine (Invitrogen). HEK293 transfection with
Lipofectamine was done for 6–8 h at 37uC. Cells were grown for
24–48 h before being used for microscopy or RNA extraction. For
OGC knock-down in MIN6 b-cells, an shRNA vector targeting
mouse OGC was employed (TG504014, OriGene). The cells were
grown in 24 well plates and transfected for 6–8 hours using 500 ng
of either OGC shRNA vector or a vector containing a scrambled
shRNA cassette as control and 1 ml Lipofectamine 2000 (Invitro-
gen) in 500 mL Opti-MEM, according to the manufacturer’s
instructions. Following transfection, MIN6 cells were cultured in
DMEM with no penicillin/streptomycin for 72 hours before the
assessment of apoptosis activation.
Microscopy
Worms were mounted on a 3% agarose pad and immobilized
with 10 mM Levamisol (Sigma-Aldrich). Fixed HEK293 cells were
mounted on microscope slides using the Vectashield mounting
solution (Vector Laboratories). Images were taken using a Zeiss
Axioskop with a QImaging Retiga 2000R camera. The imaging
software used was Openlab 5.5.0. For some images (Fig. 1G–H,
Fig. 2), we used a Zeiss Axiovert 200 M confocal microscope with
the LSM 5 Pascal laser system. Quantification of GFP reporter
expression was performed with ImageJ (Rasband WS, ImageJ, U.
S. National Institutes of Health, Bethesda, Maryland, USA,
http://rsb.info.nih.gov/ij/, 1997–2009.).
Electron microscopy
Adult worms were washed directly into a primary fixative of
2.5% glutaraldehyde in 0.1 M Sorensen phosphate buffer. Worms
were transferred to microcentrifuge tubes and fixed for one hour at
room temperature. Samples were then centrifuged at 3,000 rpm
for one minute, supernatant removed and washed for ten minutes
in 0.1 M Sorensen phosphate buffer. The worms were then post-
fixed in 1% osmium tetroxide in dH2O for one hour at room
temperature. Following washing in buffer, specimens were
processed for electron microscopy by standard methods; briefly,
they were dehydrated in ascending grades of alcohol to 100%,
infiltrated with Epon and placed in aluminum planchetes
orientated in a longitudinal aspect and polymerized at 60uC for
24 hours. Using a Leica UC6 ultramicrotome, individual worms
were sectioned in cross section at 1 mm intervals, starting outside
the worm, until the anterior tip of the animal was located as
judged by examining the sections stained with toluidine blue by
light microscopy. Thereafter, serial ultra-thin sections of 90 nm
were taken. Sections were picked onto 200 mesh copper grids,
stained with uranyl acetate and lead citrate and examined under a
Tecnai Twin (FEI) electron microscope. All mitochondrial images
were taken from muscle cells observable in anterior sections of the
worm (i.e., typically 5–15 mm from the nose tip). Where required,
sections were tilted using the Compustage of the Tecnai to ensure
an exact geometrical normalcy to the imaging system. All images
were recorded at an accelerating voltage (120 kV) and objective
aperture of 10 mm, using a MegaView 3 digital recording system.
qRT-PCR
L1 larvae synchronized by sodium hypochlorite treatment and
overnight starvation in M9 buffer were spotted on plates and
grown until day 1 of adulthood. RNA was extracted with TRIzol
(Invitrogen) and chloroform and purified with RNeasy Mini Kit
(Quiagen). Equimolar concentrations of control and experimental
RNA were used to make cDNA with SuperScript II Reverse
Transcriptase (Invitrogen). Amplification of target genes was done
with iTaq SYBR Green Supermix with ROX (Bio-Rad) using an
AB 7500 Fast Real-Time PCR System with standard settings.
Target gene expression was normalized against endogenous levels
of act-2 expression. The same protocol was followed for qRT-PCR
experiments with HEK293 cells and normalization was done with
respect to Actb expression.
Co-immunoprecipitation and Western blots
HEK293 cells were harvested in co-immunoprecipitation buffer
(25 mM TRIS pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.5% NP-
40, 1% sodium deoxycholate) with protease inhibitor cocktail
(#539134, Calbiochem). Following sonication, the solution was
pre-cleared with protein G-sepharose at slow rotation for 1.5 h at
4uC. The antibodies targeting the protein to be co-immunopre-
cipitated were then added at a concentration of 1:50 and allowed
to bind at slow rotation at 4uC overnight. The next morning
protein G-sepharose beads were added and the immunoprecipi-
tation was allowed to run at slow rotation for 4 h at 4uC. Beads
were washed four times, Laemmli buffer was added to the beads
and the protein samples were heated at 65uC for 10 min before
being loaded on an SDS-PAGE gel. Western blots were performed
using standard techniques.
We used a similar protocol for C. elegans co-immunoprecipita-
tion. Briefly, mixed stage worms were frozen at 280uC in co-
immunoprecipitation buffer. The samples were then thawed on ice
and sonified four to five times (Sonifier 450 settings: output 3 for
10 s). The lysates were then used for co-immunoprecipitation as
described above for mammalian cells. For Western blots using C.
elegans, we boiled the samples for 10 min in Laemmli buffer. We
generated an a-MISC-1 antibody with GenScript Corporation.
Other antibodies used: OGC (developed by FP); Bcl-xL (#2762,
Cell Signaling Technology); a-ANT (# MSA02) and a-Complex
IV subunit 1 (# MS404, MitoSciences). Western blots for
activation of apoptosis employed a Caspase-3 antibody (#9662,
Cell Signaling).
Staining C. elegans and HEK293 mitochondria
Mitochondria were stained with MitoTracker CMXRos
(Invitrogen). To stain mitochondria in worms, we resuspended
MitoTracker in molten (55uC) NG agar to a final concentration of
2 mg/mL. We poured 3–4 mL of the solution in 50 mm plates.
The plates were then spotted with 100 mL of OP50. Plates were
stored in the dark before and during the experiment. Synchro-
nized L1 larvae were spotted on the plates and allowed to grow
until used for microscopy on day 1 of adulthood. To stain
mitochondria in HEK293 cells, we added MitoTracker CMXRos
to fresh growth medium at a final concentration of 100 nM. The
cells were incubated at 37uC for 45 min, fixed and counterstained
with DAPI (49,6-diamidino-2-phenylindole, Sigma) according to
suppliers’ protocols.
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immunostaining
To stain apoptotic bodies in the germline, we used the dye
SYTO12 green fluorescent nucleic acid stain (Invitrogen)
according to established protocols [33].
DAPI staining was done following standard techniques.
Phospho-H3 immunostaining was performed as previously
described [73].
Metabolic assays
Glucose concentration in worms was measured with a Glucose
Assay Kit (#K606-100, BioVision) according to manufacturer’s
instructions. Briefly, synchronized day-one adults were washed 5
times in M9 buffer. The worm pellet was resuspended in 500 mL
of the glucose assay buffer provided in the kit, frozen for storage at
280uC, thawed on ice and sonified (Sonifier 450) five times
(output level 3, time 10 s) to obtain extracts. After centrifugation at
13,000 rpm at 4uC, the supernatant was used for the glucose assay
as per manufacturer’s manual. The glucose concentration was
normalized to protein content in each sample. The lysates for ATP
analysis were generated from synchronized day-one adults, which
were frozen, sonicated as described above, and boiled for 15 min.
ATP contents were assayed with the Adenosine 59-triphosphate
(ATP) Bioluminescent Assay Kit (#FL-AA, Sigma) according to
manufacturer’s instructions. Measurements of signal intensity were
taken with a Tecan M200 micro plate reader.
Statistical analyses
Results are expressed as mean 6 S.E.M. A P-value of less than
0.05 was considered significant. Statistical analyses were per-
formed with the statistical package GraphPad Prism 5.02.
Supporting Information
Figure S1 Amino acid conservation between C. elegans
MISC-1 and human OGC. MISC-1 and OGC share 72%
identity and 80% similarity (e-value=8e
2105) at the amino acid
level. The two proteins are best reciprocal matches. When doing
BLAST similarity searches with the MISC-1 sequence, the second
best human match is the dicarboxylate carrier, with an expect
value of 2e
251, amino acid identity of 39% and similarity of 57%.
BLAST similarity searches with the human OGC amino acid
sequence against the C. elegans proteome showed the second best
match as the uncharacterized protein K11G12.5, predicted to be a
malate carrier. In this case, the expect value was 8e
250, amino acid
identity was 40% and similarities were 57%. Identical amino acids
are shown in black, similarities are shown in grey.
(TIF)
Figure S2 Starvation increases MISC-1 expression. We
observed an increase in MISC-1::GFP reporter expression in
animals that were placed for 24 h on plates that contained no
food, compared to animals that were fed ad libitum on plates
streaked with E. coli OP50. The increase in reporter expression
upon starvation was especially noticeable in the posterior bulb of
the pharynx (outlined in upper right panel) and in the posterior
intestine (outlined in lower right panel).
(TIF)
Figure S3 Evaluation of misc-1 and OGC knock-down.
(A) Synchronized L1 larvae were treated with either empty vector
control (L4440) or misc-1 RNAi vector until day 1 of adulthood.
We performed a Western blot on the proteins extracted from these
strains with our MISC-1 antibody. The results show a ,84%
down-regulation of MISC-1 levels upon misc-1 RNAi treatment.
(B) Quantitative Real-Time PCR (qRT-PCR) was performed to
assess the extent of OGC knock-down in HEK293 cells treated with
OGC siRNA. As a control, we transfected cells with a mammalian
X-Scramble siRNA vector. OGC expression levels were normal-
ized to Actb. Our results indicate that OGC siRNA reduced target
gene expression by ,80%. Error bars: 6S.D.
(TIF)
Figure S4 misc-1 knock-down does not affect muscle
morphology. Control RNAi and misc-1 RNAi on a transgenic
strain carrying a myo-3p::myo-3::gfp. This transgene is expressed in
muscles and provides a tool to assess muscle morphology. These
confocal images show that muscle morphology in misc-1 RNAi-
treated worms is indistinguishable from that of control RNAi-
treated worms. The mitochondrial fragmentation phenotype
observed in Figure 2B is therefore caused by a specific effect of
misc-1 RNAi on mitochondria, not on muscle structure.
(TIF)
Figure S5 misc-1 RNAi does not compromise the ability
of the somatic gonad to remove apoptotic corpses.
Control RNAi and misc-1 RNAi treatment on a transgenic strain
carrying CED-1::GFP are shown. This fluorescent reporter allows
visualization of the apoptotic corpses being engulfed and removed
by the somatic sheath cells (arrows). We observed a two-fold
increase in the number of engulfing events per gonad arm in
worms treated with misc-1 RNAi, compared to control. This result
suggests that the increase in apoptotic events observed in Fig. 4A–
B was due to an effect of misc-1 on apoptosis, and was not caused
by a defect in the mechanism of cell corpse removal.
(TIF)
Figure S6 MISC-1 interacts with apoptotic proteins in
C. elegans. Co-immunoprecipitation experiments performed in
wild type N2 (upper panel) and in a transgenic line expressing
MISC-1::GFP (lower panel). MISC-1 was shown to interact with
CED-9 and ANT. The latter is an integral component of the
MPTP. Our data suggest that MISC-1 is a novel component of the
MPTP and therefore an important player in the induction of
apoptosis. Antibodies used: a-CED-9: sc-33737, Santa Cruz
Biotechnology, Santa Cruz CA, USA; a-GFP: ab6556, Abcam
Inc., Cambridge MA, USA. See Methods section for other
antibodies.
(TIF)
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